Nanobiotix | 20-F: Registration statement / Annual report / Transition report
Apr 24 22:19 ET
Nanobiotix | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 24 16:54 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 17 16:22 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 16:20 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 2 16:19 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 16:21 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 13 16:22 ET
Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(0%),Invus Public Equities Advisors, LLC(0%), etc.
Feb 9 17:12 ET
Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qatar Investment Authority(9.1%)
Feb 8 20:31 ET
Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Johnson & Johnson(11.9%),Johnson & Johnson Innovation-JJDC, Inc.(11.9%)
Feb 2 16:38 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 31 16:19 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 29 16:19 ET
Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(6.21%)
Jan 29 10:58 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 12 00:00 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 26, 2023 00:00 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 13, 2023 16:15 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 4, 2023 16:32 ET
Nanobiotix | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson Innovation-JJDC, Inc.(10.2%),Johnson & Johnson(10.2%)
Nov 16, 2023 16:02 ET
Nanobiotix | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 13, 2023 16:15 ET
Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 9, 2023 16:15 ET
No Data
No Data